Заявка Abalone Bio в YC

Winter 2020Active

Abalone Bio прошел Y Combinator в потоке Winter 2020 как компания из сферы Healthcare. Ниже: чем занимается компания, кто ее основал, и ее заявка в YC, реконструированная вопрос за вопросом в реальной форме YC.

Поток YC: Winter 2020
Сфера: HealthcareDrug Discovery and Delivery
Размер команды: 14
Статус: Active
Запущено: 2020

Фаундеры

Richard YuFounder
Gustavo PesceFounder

Чем занимается Abalone Bio

Abalone Bio is tackling challenging undrugged targets underlying diseases affecting millions, focusing first cell-specific antibody drugs to treat obesity and metabolic disease without the GI side effects that cause 25% of GLP-1 drug patients to quit after 1 year. + High throughput experimental measurement uniquely leverages AI/ML: We’ve engineered cells to measure antibodies for pharmacological activity, not just structure or binding like others, 100 million at a time, 100X+ the throughput of others. With our large, proprietary activity datasets, we uniquely leverage ML to both unlock the discovery of rare hits and generate optimized hits for challenging targets, starting with G-protein coupled receptors (GPCRs) + Proven success: We have developed antibody agonists (activators) for 2 out of the 8 G-protein coupled receptors ever drugged by biotech. + Pharma traction: We’ve secured 3 partnerships with $3M in revenue and $125M in downstream value. + Externally validated science: We’ve been awarded $7M in non-dilutive grant funding for platform and program development.

Заявка Abalone Bio в YC, реконструирована

Заявка Y Combinator

Abalone Bio, батч Winter 2020. Реальные вопросы из анкеты, ответы из публичных данных.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Abalone Bio

Describe what your company does in 50 characters or less.

We create activating antibodies to treat diseases others can't.

What is your company going to make? Please describe your product and what it does or will do.

We build a platform that combines high-throughput experimental antibody screening with machine learning to discover activating antibodies targeting cell-specific receptors. Our product enables discovery and optimization of rare antibody hits against challenging targets like GPCRs, starting in obesity and metabolic diseases, focusing on safety and efficacy beyond current drugs.

Where do you live now, and where would the company be based after YC?

We live in San Francisco, CA, and the company is based here.

Explain your decision regarding location.

San Francisco is a hub for biotech and AI talent, which is critical for our platform combining synthetic biology and machine learning. Being in SF keeps us close to partners and investors focused on healthcare innovation.

21 еще ответ в полной заявке

Founders, Progress, Idea, Equity, Curious, Batch Preference находятся в полной версии. Создайте бесплатную учетную запись, чтобы открыть ее в YC Insights, рядом с каждым другим потоком YC.

Смотреть полную заявку

Часто задаваемые вопросы

Это реальная заявка Abalone Bio в YC?

Нет. Y Combinator держит поданные заявки в приватности. Это реконструкция: реальные вопросы формы YC, ответы на которые основаны на публичных данных Abalone Bio (заметки о запуске, бэкграунд фаундеров, описание продукта). Это показывает, как компания вроде Abalone Bio представила бы себя YC, а не текст, который они подали.